862 studies found for:    "Hepatitis C, Chronic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
2 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
3 Completed Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Irbesartan;   Drug: placebo
4 Recruiting A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Condition: Hepatitis C, Chronic
Interventions: Drug: Simprenavir;   Drug: Daclatasvir;   Drug: Ribavarin
5 Recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
6 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
7 Completed Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients
Conditions: HIV Infections;   Hepatitis C, Chronic;   Treatment Failure
Interventions: Drug: Peginterferon alfa2a;   Drug: Ribavirin
8 Completed
Has Results
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)
9 Unknown  Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: PEG-rIL-29;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
10 Unknown  Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Conditions: Hepatitis C, Chronic;   Liver Fibrosis
Intervention: Drug: Peginterferon alpha-2b + ribavirin
11 Completed Multidisciplinary Support Program in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Multidisciplinary support program
12 Completed Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention: Drug: peginterferon alfa-2a and ribavirin
13 Withdrawn Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention:
14 Completed Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
Conditions: Hepatitis C, Chronic;   Cognition Disorders;   Fatigue Syndrome, Chronic;   Major Depressive Disorder
Intervention: Drug: Interferon and ribavirin
15 Completed Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2336805;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin;   Drug: GSK2336805 Matching Placebo
16 Recruiting Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Intervention: Biological: VGX-6150
17 Completed Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced
Condition: Hepatitis C, Chronic
Intervention: Drug: BI201335
18 Recruiting Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2878175;   Drug: Placebo
19 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
20 Active, not recruiting Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy;   Drug: Peginterferon & amp; Ribavirin for Hepatitis C;   Drug: Pre-treatment Ribavirin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years